Search
MiniMed Ord Shs (Proposed)
MMEDAdd to Watchlist
18.050USD
-0.095-0.52%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.07BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
11
analysts
Buy
Current Rating
20.600
Target Price
+11.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
MiniMed Ord Shs (Proposed)
MMED
11
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is MiniMed Ord Shs (Proposed)'s expected revenue for the next quarter?
MiniMed Ord Shs (Proposed)'s expected revenue is 828.09M.
How have MiniMed Ord Shs (Proposed)MMED's recent earnings per share performed?
The market expectation was USD -1.01, while MiniMed Ord Shs (Proposed)MMED's earnings per share (EPS) for the previous quarter was USD -1.30. EPS for the next quarter is expected at USD -0.17.
What is the analyst rating for MiniMed Ord Shs (Proposed)?
Based on the ratings of MiniMed Ord Shs (Proposed)'s stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.